Sai Life Sciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has submitted to the exchanges a Regulation 31(4) disclosure on behalf of its promoter Mr. Krishnam Raju Kanumuri. The disclosure confirms that members of the Promoter, Promoter Group, and Persons Acting in Concert have not created any new encumbrances (such as pledges or charges) on their shares during the financial year ended March 31, 2025, other than those already reported earlier in the year. The filing also includes an updated list of 48 promoter and promoter group entities (individuals, partnership firms, trusts, HUFs, and companies). This is a routine annual compliance filing required under SEBI takeover rules.
This is a neutral, routine compliance filing. It reassures shareholders that promoters have not added any new pledges or encumbrances on their holdings beyond what was already disclosed, indicating no incremental financial stress or stake-related action during the year.